You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

February 4, 2014

Web Version  |  Share with a colleague

Facebook Like   Twitter Tweet

Today's Headlines

Acute otitis media: High healthcare costs

Acute otitis media is associated with an incremental increase in outpatient healthcare costs of $314 per child per year in the United States, which translates into approximately $2.88 billion in added healthcare expense annually, according to researchers. » Full article

TRENDING NOW

Check out this week's top searches
from your colleagues.

1. Affordable Care Act: Sebelius predicts pressure on narrow networks

2. Cardiovascular disease: Optimal adherence to meds prescribed post-heart attack lowers hospital readmissions

3. Cancer: Single-payer system endorsed by oncologists

4. Medical innovation: Progress in treating cancer continues to surge

5. Healthcare technology: EHR use growing, but unevenly

Continuing Education

New CPE: Clinical Updates in Diabetes Care

This month, Drug Topics offers “Clinical Updates in Diabetes Care,” a knowledge-based activity worth up to 2 credits. The goal of this activity is to assist pharmacists in recognizing and understanding the changes in diabetes care to provide optimal evidence-based care for patients with diabetes. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

EDITOR'S PICK

Holes in the drug marketplace: How do we overcome these obstacles?

Complex diseases present complex challenges for researchers, clinicians, drug manufacturers, and FDA for a variety of reasons. The impact, however, is felt at the patient level, particularly when there are no FDA-approved treatments. In some cases, such as myalgic encephalomyelitis, commonly known as chronic fatigue syndrome, the devastating effects of the disease are exacerbated by the huge deficit in the drug application and approval pipeline. This leaves the patient population with little hope. » Full article

 

Related Articles

Treat critically ill kids with flu fast with NAIs

Drug shortages have big impact on patient care

RESOURCES

Drug Watch

Latest Clinical News

 
Powered by Modern Medicine Advanstar Medical Communications Group